Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ameriphysics is a private U.S. radiation health-physics and radiological services company focused on decontamination and decommissioning, health physics support, radioactive waste management, and cyclotron decommissioning. The company serves complex radiological facilities, including research reactors, laboratories, and radioisotope production sites, and holds a U.S. Nuclear Regulatory Commission radioactive materials license authorizing site characterization, waste management, training, and D&D work. Founded in 2008, Ameriphysics states that it became the first U.S. firm specifically licensed to decommission cyclotrons in 2009 and has completed more than 260 projects. Its business appears to be service-based rather than drug-development based, with expertise in MARSSIM final status surveys, regulatory support, and turnkey project execution for radiological cleanup and license termination.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ameriphysics.